Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Robohogs who wrote (9932)	1/31/2007 10:07:20 PM
From: double_down97	Respond to of 10280

Robohogs, I want to thank you for your insightful posts and sharing your thoughts and knowledge on Sepracor. Like everyone, I was disappointed in todays investor call and stock price action and I'm hoping it put in a near term bottom. The only thing I can add to your post is that Sepracor filled an open "up" gap at today at $58.15 and the fall today created a new "down" gap at $60.15. The stock has consistently filled these gaps in past so getting back to the $60 level is not out of the question. It's just a matter of when?? Thanks again. dd

To: Robohogs who wrote (9932)	1/31/2007 10:39:18 PM
From: Rocky9	Respond to of 10280

Thanks for the comments. I have been concerned that SEPR was ahead of itself (from a price standpoint). My main concern has to do with generic Ambien. It clearly doesn't seem to concern SEPR management much, but it will be interesting to watch. I too have not been writing puts at these levels. If we get back into the low 50s, I will probably start again. SEPR still should be attractive to big pharma, but when is still a big question.

To: Robohogs who wrote (9932)	2/1/2007 8:38:29 AM
From: kenhott	Respond to of 10280

What do they say? Those who can't do, teach (kidding). It is a lot easier to write about a trade than to do the trade. Nobody is perfect. SEPR is a wonderful trading vehicle. In a stock that moves like SEPR, it pays to be forgetful about buyouts. Just basic math. One can make more $ trading the ups and downs then the holding for the actual buyout. I definitely think that SEPR is still in a range. The rock around SEPR's neck is generic ambien. The hope is a buyout. But I think the range is wider now than recent, more to the downside. I am not holding for buyout but I am fishing for buyout with cheap options selectively.